Hunter Diabetes Centre

18/05/2026

15/02/2026

FIRST TYPE 1 DIABETES CATCH UP FOR A NEW YEAR

Come along and meet other people living with Type 1 Diabetes in a relaxed, casual, non-clinical and completely non-judgmental setting. Whether you’re keen for drinks, dinner, or just a friendly chat — you’re welcome! Partners are too. ❤️

📅 Wednesday 25th February 2026
⏰ 6:30 PM
📍 South’s Merewether

A great chance to connect, share experiences, and enjoy some festive cheer together.

👉 Please RSVP today 49632323

Hope to see you there!

09/02/2026

🧡 Now Available at Hunter Diabetes – Fibro Scans 🩺

Curious about your liver health? A Fibro Scan is a quick, painless and non-invasive test (similar to an ultrasound) that measures liver scarring and fatty changes.

📅 Talk to reception today to book your Fibro Scan! 0249632323

$ fees apply

01/12/2025

⚠️ Product warnings updated for GLP-1 RA class⚠️

*Content advice – this post contains reference to su***de*

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues.

This relatively new and high-profile class of medicines is used to treat type 2 diabetes mellitus and/or obesity.

Medicines in the GLP-1 RA class currently marketed in Australia are:
• Ozempic (semaglutide)
• Wegovy (semaglutide)
• Saxenda (liraglutide)
• Trulicity (dulaglutide)
• Mounjaro (tirzepatide)

1. Potential risk of suicidal thoughts
Product warnings across the GLP-1 RA class of medicines have been aligned to ensure consistent information regarding the potential risk of suicidal thoughts or behaviours.

The updates follow investigations by TGA and other international regulators.

Patients taking any of these medicines should tell their health professional if they experience new or worsening depression, suicidal thoughts or any unusual changes in mood or behaviour.

If you or anyone you know needs help, call Lifeline on 13 11 14.

2. Mounjaro (tirzepatide) and contraception
Our investigation into the potential for reduced effectiveness of oral contraception when first taking or increasing the dose of Mounjaro (tirzepatide) has found that this association could not be ruled out.

As a precautionary measure, the product warnings for tirzepatide have been updated to include further advice for patients using oral contraceptives. Patients taking tirzepatide are advised to switch to a non-oral contraceptive or add a barrier method of contraception for 4 weeks after first taking the medicine and for 4 weeks after each increase in the dose.

None of the GLP-1 RAs should be used during pregnancy and individuals of childbearing potential are advised to use effective contraception during treatment with a GLP-1 RA.

Read more: https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/product-warnings-updated-glp-1-ra-class

01/12/2025

💙 Our final Type 1 Diabetes catch-up for 2025! 💙

Thank you to everyone who joined us throughout the year — we truly love seeing your happy faces each month. Your support and connection make these catch-ups so special.

A big thank you to Annette for facilitating and keeping this group running so beautifully.

✨We look forward to seeing you all again next year!

01/12/2025

💙 Last month we celebrated Diabetes Awareness and held a fun guessing competition, for those that had a guess the number was 267, our winner was one number off.

We also had our 50 club, sold all numbers. Thanks to everyone who joined in. See video for winner announcement.

All money raised has been donated to Breakthrough Diabetes. Thank you everyone.

If anyone would like to contribute further, the donation link is below. 💙

https://breakthrought1d.org.au/get-involved/ways-to-give/donate/

28/11/2025

I watched this today and thought it may inspire somebody struggling with their diabetes

25/11/2025

🎄 TYPE 1 DIABETES CATCH UP 🎄

Come along to OUR LAST CATCH FOR THE YEAR and meet other people living with Type 1 Diabetes in a relaxed, casual, non-clinical and completely non-judgmental setting. Whether you’re keen for drinks, dinner, or just a friendly chat — you’re welcome! Partners are too. ❤️

📅 Wednesday 26th November 2025
⏰ 6:30 PM
📍 South’s Merewether

A great chance to connect, share experiences, and enjoy some festive cheer together.

👉 Please RSVP today 49632323

Hope to see you there! 🎅✨

13/10/2025

TYPE 1 CATCH UP - Wednesday 29th October

Meet other people with type 1 diabetes in a casual social setting. come for drinks, dinner or just a chat! Partners and family are welcome.

RSVP by Monday 20th October

30/09/2025

🚨 Doctors Wanted – GP / Research Doctor (Newcastle, NSW) 🚨

Join Hunter Diabetes Centre & AIM Research and be part of groundbreaking clinical trials in diabetes, cardiology, weight loss & more.

✨ $150/hr (neg. with experience)
✨ 3–5 days per week, Mon–Fri
✨ No weekends, no late nights
✨ Be part of local & global research

📍 Must be AHPRA-registered and based in (or willing to move to) Newcastle/Hunter region.

About the Role:
You’ll support our Principal Investigator in running high-quality clinical trials — from recruiting patients, conducting exams, and administering treatments, to ensuring compliance and patient care.

🔗 Learn more:
www.hunterdiabetescentre.com.au

www.aimresearch.com.au

💡 Make a real impact in research while enjoying work-life balance in beautiful Newcastle!

👉 Interested? Send your CV to Avril – [email protected]
or Michaela - [email protected]

We are looking for a GP / CMO / Research Doctor / Sub-Investigator to join our Clinical Research Team 3 - 5 days a week, no weekends or late nights.